CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AC4. A total of 14 filers reported holding CLOVIS ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,685,000 | -0.1% | 2,408,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,686,000 | -25.3% | 2,408,000 | -19.9% | 0.00% | 0.0% |
| Q1 2022 | $2,256,000 | +7.9% | 3,008,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $2,091,000 | -58.3% | 3,008,000 | -56.8% | 0.00% | -66.7% |
| Q3 2021 | $5,018,000 | -1.7% | 6,958,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $5,103,000 | -12.4% | 6,958,000 | -9.7% | 0.00% | -25.0% |
| Q1 2021 | $5,824,000 | +5.9% | 7,708,000 | -2.8% | 0.00% | +33.3% |
| Q4 2020 | $5,502,000 | -0.9% | 7,933,000 | 0.0% | 0.00% | -25.0% |
| Q3 2020 | $5,552,000 | +15.6% | 7,933,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $4,803,000 | +2.5% | 7,933,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $4,688,000 | -5.8% | 7,933,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $4,978,000 | +50.2% | 7,933,000 | 0.0% | 0.00% | +33.3% |
| Q3 2019 | $3,315,000 | -32.8% | 7,933,000 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $4,935,000 | -20.0% | 7,933,000 | +0.3% | 0.00% | -33.3% |
| Q1 2019 | $6,167,000 | +388.3% | 7,908,000 | +338.1% | 0.01% | +500.0% |
| Q4 2018 | $1,263,000 | – | 1,805,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|